This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with their permission for educational and informational purposes only and is not certified for continuing education credits.

Home  >  Obesity  >  Disease Education  > Burden of Obesity Infographic

disease education
obesity Interactive

Burden of Obesity Infographic

Interactive data visualizations showing the health and economic costs of living with obesity.

View
A link has been copied to your clipboard.

Paste it into your email or chat app to share

Close

Obesity Impacts:

Quality of Life, Well-being, and Work Productivity

Obesity Impairs Psychological Well-being

Obesity leads to1:

Lower self-esteem

Higher body image
dissatisfaction

Body shape concerns

View supporting data

Close supporting data

Self-esteem

Self-esteem is lower in women considered overweight or obese compared with women with standard BMI1,a,b

Body Image Dissatisfaction

Each increase in BMI category increases body image dissatisfaction1,a,c

Body Shape Concerns

Body shape concerns are higher in women considered overweight and increase further in women with obesity1,a,d

Individuals who are overweight or obese may experience weight stigma2

There are a variety of consequences associated with experiencing weight stigma, including:

Poor body image and greater likelihood of psychiatric disorders, including a major depressive episode2,3

Increase in calories consumed and avoidance of exercise4,5

BMI = body mass index (kg/m2)

aOrthogonal contrasts using linear regression adjusting for age and treatment group; women with obesity or considered overweight are compared with women considered standard weight.
bComparisons between normal weight and overweight or obese; P<0.001.
cComparisons between normal weight and overweight or obese, non-obese and obese, and obesity I and obesity II; P<0.001.
dComparisons between normal weight and overweight or obese and non-obese and obese; P<0.001.

1. Vieira PN et al. Obes Facts. 2012;5(6):795-805. 2. Puhl RM et al. Clin Diabetes. 2016;34(1):44-50. 3. Hatzenbuehler ML et al. Obesity (Silver Spring). 2009;17(11):2033-2039. 4. Schvey NA et al. Obesity (Silver Spring). 2011;19(10):1957-1962. 5. Vartanian LR and Novak SA. Obesity (Silver Spring). 2011;19(4):757-762.

Obesity Impairs Health-Related Quality of Life

Obesity leads to1:

Lower weight-related
quality of life

Lower physical health-related
quality of life

View supporting data

Close supporting data

Weight-Related HRQoL

Each increase in BMI category decreases weight-related quality of lifea,b

HRQoL: Physical Health

Physical health-related quality of life is lower in women with obesity compared with non-obese womena,c

HRQoL: Mental Health

Mental health scores are similar across weight groups

BMI = body mass index (kg/m2); HRQoL = health-related quality of life.

aOrthogonal contrasts using linear regression adjusting for age and treatment group; women with obesity or considered overweight are compared with women considered standard weight.
bComparisons between normal weight and overweight or obese, non-obese and obese, and class I obesity and class II obesity; P<0.001.
cComparison between non-obese and obese; P=0.001.

Vieira PN et al. Obes Facts. 2012;5:795-805.

Obesity-Related Complications Impact the Ability to Work

Obesity with comorbid
conditions leads toa:

Greater work
productivity loss

Higher absenteeism
and presenteeism

Greater activity
impairment

View supporting data

Close supporting data

Work Productivity/Activity Impairment Scoresb,c

With each additional comorbidity, mean scores across each measure increase

BMI = body mass index (kg/m2)

aOverweight or obese individuals (BMI >27 kg/m2) with 1, 2, or 3 related complications, compared with overweight or obese individuals (BMI >27 kg/m2) with 0 complications.bData obtained from the 2006 National Health and Wellness Survey; analysis specific to work productivity was limited to respondents <65 years of age and employed full-time.
cData show self-reported work productivity and activity impairment scores among overweight or obese individuals (BMI >27 kg/m2) with 0, 1, 2, or 3 related complications.
dObesity-related complications include type 2 diabetes (T2D), hypertension, and high cholesterol.

Kannan H et al. J Occup Environ Med. 2008;50(5):542-549.

Explore additional evidence-based resources on a variety of topics important to patient care.

obesity

disease education
View Resources
pharmacotherapies
View Resources
congress materials
View Resources

Other Therapy Areas

Explore resources in other therapeutic areas investigated by Novo Nordisk. All information is for educational purposes only and is not intended to promote any products.

Diabetes Icon

Diabetes

Explore Type 1
Explore Type 2
Obesity Icon

Obesity

Explore
Rare Blood Disorders Icon

Rare Blood
Disorders

Explore
Rare Endocrine Disorders icon

Rare Endocrine
Disorders

Explore
NASH Icon

NASH

Explore

Search the Exchange

The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products. It provides evidence-based information on a variety of topics important to patient care. All information is for educational purposes only and is not intended to promote any products.

Novo Nordisk® Scientific Exchange logo

Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.